The natural interleukin-1 receptor antagonist in tem and preterm parturition
Open Access
- 1 October 1992
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (4) , 863-872
- https://doi.org/10.1016/s0002-9378(12)80003-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.Journal of Clinical Investigation, 1992
- Production of interleukin-1-receptor antagonist during experimental endotoxaemiaThe Lancet, 1991
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.Journal of Clinical Investigation, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Enhancement of Growth of Virulent Strains of Escherichia coli by Interleukin-1Science, 1991
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinNature, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Native interleukin 1 inhibitorsImmunology Today, 1989
- Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).Journal of Clinical Investigation, 1986